STOCK TITAN

Enova International (NYSE: ENVA) chair exercises options and sells 28,500 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Enova International Executive Chairman David Fisher reported an exercise-and-sell sequence over July 14–15, 2026. He exercised options for a total of 28,500 common shares at $20.73 per share and sold the same number in open-market transactions at weighted-average prices of $231.454 and $231.5061 per share.

Following these transactions, Fisher directly holds 306,444 Enova common shares and 184,682 non-qualified stock options with a $20.73 exercise price expiring on February 11, 2027. The options vested in substantially equal one-third increments in 2021, 2022, and 2023.

Positive

  • None.

Negative

  • None.
Insider Fisher David
Role Executive Chairman
Sold 28,500 shs ($6.60M)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) with limited SAR 11,494 $0.00 --
Exercise Common stock, par value $0.00001 per share 11,494 $20.73 $238K
Sale Common stock, par value $0.00001 per share 11,494 $231.454 $2.66M
Exercise Non-Qualified Stock Option (right to buy) with limited SAR 17,006 $0.00 --
Exercise Common stock, par value $0.00001 per share 17,006 $20.73 $353K
Sale Common stock, par value $0.00001 per share 17,006 $231.5061 $3.94M
Holdings After Transaction: Non-Qualified Stock Option (right to buy) with limited SAR — 184,682 shares (Direct); Common stock, par value $0.00001 per share — 317,938 shares (Direct)
Footnotes (1)
  1. This transaction was executed in multiple trades at prices ranging from $229.9452 to $233.6532. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $225.64 to $235.4298. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
Shares sold July 14, 2026 17,006 shares at $231.5061 per share Open-market sale of common stock by Executive Chairman David Fisher
Shares sold July 15, 2026 11,494 shares at $231.4540 per share Open-market sale of common stock by Executive Chairman David Fisher
Options exercised July 14, 2026 17,006 shares at $20.73 exercise price Exercise of non-qualified stock options for Enova common stock
Options exercised July 15, 2026 11,494 shares at $20.73 exercise price Exercise of non-qualified stock options for Enova common stock
Common shares held after transactions 306,444 shares Direct Enova common stock holdings by David Fisher following reported trades
Options outstanding after transactions 184,682 options at $20.73, expiring 2027-02-11 Remaining non-qualified stock options with tandem SAR held by David Fisher
Non-Qualified Stock Option financial
"Security title: "Non-Qualified Stock Option (right to buy) with limited SAR""
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
stock appreciation right ("SAR") financial
"The limited stock appreciation right ("SAR") and employee stock option were granted"
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
tender offer or exchange offer regulatory
""Offer" means any tender offer or exchange offer for outstanding shares of Issuer"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transactions did Enova (ENVA) Executive Chairman David Fisher report in this Form 4?

David Fisher reported exercising options for 28,500 Enova shares at $20.73 per share and selling 28,500 common shares in open-market trades at weighted-average prices of $231.454 and $231.5061 per share over July 14–15, 2026.

How many Enova (ENVA) shares does David Fisher own after the reported transactions?

After the reported activity, David Fisher directly owns 306,444 shares of Enova common stock. This total reflects his holdings following the option exercises and related open-market sales disclosed for July 14 and July 15, 2026, in the Form 4.

What Enova (ENVA) stock options does David Fisher still hold after these trades?

Fisher continues to hold 184,682 non-qualified stock options on Enova common stock with an exercise price of $20.73 per share, expiring on February 11, 2027. These options are paired with a limited stock appreciation right as described in the filing footnotes.

Were David Fisher’s Enova (ENVA) share sales single trades or multiple trades?

Both reported sales were executed in multiple trades within specified price ranges. The prices reported, $231.454 and $231.5061 per share, are weighted-average sale prices, and detailed trade-level information is available upon request as noted in the footnotes.

How did David Fisher’s Enova (ENVA) option grants vest?

The options underlying these transactions vested in substantially equal one-third increments on February 11, 2021, February 11, 2022, and February 11, 2023. This vesting schedule applied to the non-qualified stock options exercised in the July 2026 trades.

What is the limited stock appreciation right (SAR) mentioned in David Fisher’s Enova (ENVA) filing?

The filing explains that the limited stock appreciation right (SAR) is granted in tandem with the employee stock option. Exercising one causes the other to expire and, if certain change-in-control and offer conditions are met, can pay an amount based on the share price above $20.73.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fisher David

(Last)(First)(Middle)
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600

(Street)
CHICAGO ILLINOIS 60604

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Executive Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock, par value $0.00001 per share07/14/2026M17,006A$20.73323,450D
Common stock, par value $0.00001 per share07/14/2026S17,006D$231.5061(1)306,444D
Common stock, par value $0.00001 per share07/15/2026M11,494A$20.73317,938D
Common stock, par value $0.00001 per share07/15/2026S11,494D$231.454(2)306,444D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)$20.7307/14/2026M17,006 (5)02/11/2027Common stock; par value $0.00001 per share17,006$0196,176D
Non-Qualified Stock Option (right to buy) with limited SAR(3)(4)$20.7307/15/2026M11,494 (5)02/11/2027Common stock; par value $0.00001 per share11,494$0184,682D
Explanation of Responses:
1. This transaction was executed in multiple trades at prices ranging from $229.9452 to $233.6532. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
2. This transaction was executed in multiple trades at prices ranging from $225.64 to $235.4298. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
3. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
4. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
5. The options vested in substantially equal one-third increments on each of the following dates: February 11, 2021, February 11, 2022, and February 11, 2023.
/s/ Sean Rahilly, as attorney in fact07/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)